Literature DB >> 25832677

Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China.

Jun Liu1, Zhongliang Zhou, Shimin Yang, Bianling Feng, Jun Zhao, Hua Liu, Haiyan Huang, Yu Fang.   

Abstract

BACKGROUND: Hospital pharmacists can make a considerable contribution to the spontaneous reporting system of adverse drug reactions. The factors that influence adverse drug reaction reporting among hospital pharmacists remain largely unknown in China.
OBJECTIVE: This study aims to identify factors that affect hospital pharmacist-led adverse drug reaction reporting in Xi'an, and to obtain suggestions from pharmacists about how to improve the current adverse drug reaction reporting system.
SETTING: Hospital settings throughout Xi'an, a region of Western China.
METHOD: A matched case-control study was conducted on a population of 2,814 hospital pharmacists in Xi'an during 2011. Cases included all pharmacists who had reported at least one adverse drug reaction between 2008 and 2010 and agreed to participate in the study (186/204; 91.2 %); controls (n = 372) were pharmacists who had not reported any adverse drug reaction during the same period. A self-administered questionnaire was distributed to the participants. Logistic regression was performed to evaluate the association between indicator variables and the outcome of having reported at least one adverse drug reaction. MAIN OUTCOME MEASURE: Pharmacists' knowledge, attitude and practice towards adverse drug reaction reporting and factors affecting reporting.
RESULTS: Higher professional title (adjusted OR 1.44; 95 % CI 1.07-1.94; p = 0.018), having received training about adverse drug reaction reporting (1.64; 1.04-2.57; p = 0.032), better knowledge about reporting (1.53; 1.12-2.08; p = 0.007), "lack of access to adverse drug reaction reporting form" (0.29; 0.12-0.72; p = 0.008) was independently associated with adverse drug reaction reporting. Clinical pharmacists were more likely to report an adverse drug reaction than dispensary pharmacists (1/adjusted OR 5.26; p < 0.001), pharmacy administrators (5.00; p = 0.003), and other technicians (5.56; p = 0.001).
CONCLUSIONS: Higher professional title, having received training, mastering knowledge about reporting, and being a clinical pharmacist were positive predictors of pharmacist-led adverse drug reaction reporting. Lack of access to reporting forms was a negative predictor. Continuous training and establishing incentive mechanisms are needed to promote adverse drug reaction reporting among hospital pharmacists.

Entities:  

Mesh:

Year:  2015        PMID: 25832677     DOI: 10.1007/s11096-015-0065-8

Source DB:  PubMed          Journal:  Int J Clin Pharm


  36 in total

1.  Physicians' attitudes towards voluntary reporting of adverse drug events.

Authors:  A Figueiras; F Tato; J Fontaiñas; B Takkouche; J J Gestal-Otero
Journal:  J Eval Clin Pract       Date:  2001-11       Impact factor: 2.431

2.  Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA.

Authors:  S R Ahmad; J P Freiman; D J Graham; R C Nelson
Journal:  Pharmacoepidemiol Drug Saf       Date:  1996-01       Impact factor: 2.890

Review 3.  Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.

Authors:  María T Herdeiro; Jorge Polonia; Juan J Gestal-Otero; Adolfo Figueiras
Journal:  J Eval Clin Pract       Date:  2004-11       Impact factor: 2.431

4.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Clinical pharmacy education in China.

Authors:  Melody Ryan; Hong Shao; Li Yang; Xiao-Yan Nie; Suo-Di Zhai; Lu-Wen Shi; William C Lubawy
Journal:  Am J Pharm Educ       Date:  2008-12-15       Impact factor: 2.047

6.  Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.

Authors:  Elisabet Ekman; M Bäckström
Journal:  Eur J Clin Pharmacol       Date:  2008-09-30       Impact factor: 2.953

7.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

8.  Pharmacy practice and education in the People's Republic of China.

Authors:  H C Wang; L Y Chen; A H Lau
Journal:  Ann Pharmacother       Date:  1993-10       Impact factor: 3.154

Review 9.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

10.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Jacob O Awobusuyi
Journal:  BMC Clin Pharmacol       Date:  2009-08-11
View more
  4 in total

Review 1.  Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting.

Authors:  Muhammad Abdul Hadi; Chin Fen Neoh; Rosdi M Zin; Mahmoud E Elrggal; Ejaz Cheema
Journal:  Integr Pharm Res Pract       Date:  2017-03-22

2.  Post-Marketing Safety Surveillance of the Salvia Miltiorrhiza Depside Salt for Infusion: A Real World Study.

Authors:  Ying-Ying Yan; Yi-Heng Yang; Wei-Wei Wang; Yu-Ting Pan; Si-Yan Zhan; Ming-Yang Sun; Hong Zhang; Suo-Di Zhai
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

3.  Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.

Authors:  Tahmine Salehi; Naiemeh Seyedfatemi; Mohammad Saeed Mirzaee; Maryam Maleki; Abbas Mardani
Journal:  Biomed Res Int       Date:  2021-04-09       Impact factor: 3.411

4.  A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan.

Authors:  Rabia Hussain; Mohamed Azmi Hassali; Furqan Hashmi; Maryam Farooqui
Journal:  J Pharm Policy Pract       Date:  2018-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.